UP AND UP ALLERGY RELIEF- fexofenadine hydrochloride tablet, film coated 
Target Corporation

----------

Target Corporation Allergy Relief Drug Facts

Active ingredient (in each tablet)

Fexofenadine HCl 180 mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

runny nose
itchy, watery eyes
sneezing
itching of the nose or throat

Warnings

Do not use

if you have ever had an allergic reaction to this product or any of its ingredients.

Ask a doctor before use if you have

kidney disease. Your doctor should determine if you need a different dose.

When using this product

do not take more than directed
do not take at the same time as aluminum or magnesium antacids
do not take with fruit juices (see Directions)

Stop use and ask a doctor if

an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

adults and children 12 years of age and over

take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours

children under 12 years of age

do not use

adults 65 years of age and older

ask a doctor

consumers with kidney disease

ask a doctor

Other information

do not use if printed blister unit is broken or torn
store between 20° -25°C (68° -77°F)
protect from excessive moisture
this product meets the requirements of USP Dissolution Test 2

Inactive ingredients

colloidal silicon dioxide, croscarmellose sodium, FD&C blue #2 aluminum lake, FD&C red #40 aluminum lake, FD&C yellow #6 aluminum lake, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, pregelatinized starch, talc, titanium dioxide

Questions?

Call 1-888-547-7400

Package/Label Principal Display Panel

Compare to active ingredient in Allegra® Allergy

non-drowsy

allergy relief

fexofenadine hydrochloride tablets 180 mg/antihistamine

indoor/outdoor allergy relief

• sneezing

• runny nose

• itchy, watery eyes

• itchy nose or throat

ACTUAL SIZE

24 HOUR

15 TABLETS

15 TABLETS

allergy relief image
UP AND UP ALLERGY RELIEF 
fexofenadine hydrochloride tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11673-617
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
FEXOFENADINE HYDROCHLORIDE (UNII: 2S068B75ZU) (FEXOFENADINE - UNII:E6582LOH6V) FEXOFENADINE HYDROCHLORIDE180 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColorPINKScoreno score
ShapeOVALSize18mm
FlavorImprint Code L847
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11673-617-2215 in 1 CARTON09/30/2021
11 in 1 BLISTER PACK; Type 0: Not a Combination Product
2NDC:11673-617-391 in 1 CARTON09/17/2021
230 in 1 BOTTLE; Type 0: Not a Combination Product
3NDC:11673-617-001 in 1 CARTON09/30/2021
340 in 1 BOTTLE; Type 0: Not a Combination Product
4NDC:11673-617-011 in 1 CARTON09/30/2021
470 in 1 BOTTLE; Type 0: Not a Combination Product
5NDC:11673-617-471 in 1 CARTON09/30/2021
5150 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA21297109/17/2021
Labeler - Target Corporation (006961700)

Revised: 9/2021
Document Id: 642da0b5-69e6-4219-ae21-a5443b5fba2c
Set id: 4f72589d-57e7-4c61-b29c-80636f0bd220
Version: 2
Effective Time: 20210930
 
Target Corporation